Ossianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics

By WebmasterDecember 17, 2014November 1st, 2024No Comments

Ossianix Expands and Extends its Research Collaboration with Lundbeck on CNS Therapeutics
Read More Here

Previous PostRelmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone
Next PostMelior Discovery Awarded SBIR Grant for Studying MLR-1023 Mechanism of Action